DCE-MRI与DSC-MRI鉴别高级别与低级别胶质瘤的诊断价值:一项综合Meta分析
该系统评价纳入2005年1月至2016年12月间22项研究,评估DCE-MRI参数Ktrans、Ve、Kep及DSC-MRI参数rCBV、rCBF鉴别胶质瘤级别的诊断效能。高级别胶质瘤的Ktrans、Ve、rCBV、rCBF均高于低级别(P<.05),Kep差异无统计学意义(P=.07);rCBV的AUC最大(0.93,P<.05)。作者认为两种技术均可靠,rCBV最敏感。
要点
- rCBV鉴别胶质瘤级别的AUC为0.93,在四个参数中最大(P<.05)。
- 高级别胶质瘤Ktrans、Ve、rCBV、rCBF均高于低级别胶质瘤,差异有统计学意义。
- Kep在高低级别胶质瘤间差异无统计学意义(P=.07)。
核心结论
- DCE-MRI与DSC-MRI均能可靠鉴别胶质瘤级别,其中rCBV最敏感。
研究设计与样本
- Meta分析,系统检索Medline、PubMed、中国知网、Cochrane图书馆和Embase,纳入2005年1月至2016年12月发表的22项研究;采用Review Manager 5.2计算标准化均数差及95%CI,Stata 12.0计算敏感度、特异度、AUC及Begg检验。
关键影像表现/征象
- 高级别胶质瘤Ktrans值高于低级别胶质瘤,标准化均数差为1.18(95%CI 0.91–1.45)。
- 高级别胶质瘤Ve值高于低级别胶质瘤,标准化均数差为1.43(95%CI 1.06–1.80)。
- 高级别胶质瘤rCBV值高于低级别胶质瘤,标准化均数差为1.44(95%CI 1.08–1.81)。
- 高级别胶质瘤rCBF值高于低级别胶质瘤,标准化均数差为1.17(95%CI 0.68–1.67)。
- Kep值在高低级别胶质瘤间差异无统计学意义(P=.07),标准化均数差为0.65(95%CI -0.05–1.36)。
诊断标准与关键数值
- Ktrans鉴别胶质瘤级别的AUC为0.90。
- Ve鉴别胶质瘤级别的AUC为0.88。
- rCBV鉴别胶质瘤级别的AUC为0.93,为四个参数中最大(P<.05)。
- rCBF鉴别胶质瘤级别的AUC为0.73。
临床应用与阅片要点
- DCE-MRI的Ktrans、Ve及DSC-MRI的rCBV、rCBF均可用于胶质瘤级别鉴别,rCBV诊断效能最高。
- Kep值在高低级别胶质瘤间差异无统计学意义,不推荐单独用于分级(原文未直接给出推荐,此为基于结果的归纳)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to collect the studies on the role of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and dynamic susceptibility contrast MRI (DSC-MRI) in differentiating the grades of gliomas, and evaluate the diagnostic performances of relevant quantitative parameters in glioma grading.
MATERIALS AND METHODS: We systematically searched studies on the diagnosis of gliomas with DCE-MRI or DSC-MRI in Medline, PubMed, China National Knowledge Infrastructure database, Cochrane Library, and Embase published between January 2005 and December 2016. Standardized mean differences and 95% confidence intervals were calculated for volume transfer coefficient (Ktrans), volume fraction of extravascular extracellular space (Ve), rate constant of backflux (Kep), relative cerebral blood volume (rCBV), and relative cerebral blood flow (rCBF) using Review Manager 5.2 software. Sensitivity, specificity, area under the curve (AUC), and Begg test were calculated by Stata 12.0.
RESULTS: Twenty-two studies with available outcome data were included in the analysis. The standardized mean difference of Ktrans values between high-grade glioma and low-grade glioma were 1.18 (0.91, 1.45); Ve values were 1.43 (1.06, 1.80); Kep values were 0.65 (-0.05, 1.36); rCBV values were 1.44 (1.08, 1.81); and rCBF values were 1.17 (0.68, 1.67), respectively. The results were all significant statistically (P < .05) except Kep values (P = .07), and high-grade glioma had higher Ktrans, Ve, rCBV, and rCBF values than low-grade glioma. AUC values of Ktrans, Ve, rCBV, and rCBF were 0.90, 0.88, 0.93, and 0.73, respectively; rCBV had the largest AUC among the four parameters (P < .05).
CONCLUSION: Both DCE-MRI and DSC-MRI are reliable techniques in differentiating the grades of gliomas, and rCBV was found to be the most sensitive one.
引用
- Liang J, Liu D, Gao P, et al. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis. Acad Radiol. 2017. PMID: 29223713. doi:10.1016/j.acra.2017.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。